Intron 10 was targeted with two sgRNAs using CRISPR/Cas9 technology, resulting in a 268 bp deletion (GRCm39:chr17:27178158-27178425). This deletion eliminates the alternative 3' splice acceptor site that is used for NMD-mediated transcriptional regulation. (J:334714)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count